The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...
ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Sept. 8, 2025 /PRNewswire/ -- Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug ...
GRAND RAPIDS, Mich. — A West Michigan family is spreading the word about their daughter's rare diagnosis in the hopes of funding research about Pyruvate Dehydrogenase Complex Deficiency (PDCD). Andrew ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback